Geode Capital Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
363,188
+12,301
| +4% | +$42.2K | ﹤0.01% | 3265 |
|
|
2025
Q1 | $782K | Buy |
350,887
+237,114
| +208% | +$529K | ﹤0.01% | 3391 |
|
|
2024
Q4 | $333K | Buy |
113,773
+120
| +0.1% | +$352 | ﹤0.01% | 3728 |
|
|
2024
Q3 | $295K | Sell |
113,653
-201,213
| -64% | -$523K | ﹤0.01% | 3773 |
|
|
2024
Q2 | $932K | Buy |
314,866
+57,500
| +22% | +$170K | ﹤0.01% | 3334 |
|
|
2024
Q1 | $1.17M | Buy |
257,366
+1,222
| +0.5% | +$5.54K | ﹤0.01% | 3308 |
|
|
2023
Q4 | $1.46M | Buy |
256,144
+846
| +0.3% | +$4.83K | ﹤0.01% | 3205 |
|
|
2023
Q3 | $1.17M | Buy |
255,298
+3,624
| +1% | +$16.7K | ﹤0.01% | 3256 |
|
|
2023
Q2 | $1.63M | Sell |
251,674
-1,923,874
| -88% | -$12.4M | ﹤0.01% | 3177 |
|
|
2023
Q1 | $16.4M | Buy |
2,175,548
+108,035
| +5% | +$815K | ﹤0.01% | 1932 |
|
|
2022
Q4 | $20.9M | Buy |
2,067,513
+82,316
| +4% | +$834K | ﹤0.01% | 1742 |
|
|
2022
Q3 | $19.6M | Buy |
1,985,197
+55,399
| +3% | +$548K | ﹤0.01% | 1750 |
|
|
2022
Q2 | $20.6M | Buy |
1,929,798
+1,727,090
| +852% | +$18.4M | ﹤0.01% | 1755 |
|
|
2022
Q1 | $1.98M | Buy |
202,708
+840
| +0.4% | +$8.19K | ﹤0.01% | 3264 |
|
|
2021
Q4 | $2.89M | Buy |
201,868
+170,204
| +538% | +$2.43M | ﹤0.01% | 3189 |
|
|
2021
Q3 | $634K | Sell |
31,664
-167,074
| -84% | -$3.35M | ﹤0.01% | 3917 |
|
|
2021
Q2 | $4.37M | Buy |
198,738
+3,201
| +2% | +$70.4K | ﹤0.01% | 2985 |
|
|
2021
Q1 | $6.64M | Buy |
195,537
+5,431
| +3% | +$184K | ﹤0.01% | 2637 |
|
|
2020
Q4 | $7.65M | Buy |
+190,106
| New | +$7.65M | ﹤0.01% | 2337 |
|